| 1 | Are There Less Toxic Alternatives to the Extreme Regimen 2016-08-03 |
Play |
| 2 | Promising Early Data for Oral Inhibitor Buparlisib 2016-08-03 |
Play |
| 3 | Using Immunotherapy as First-Line Treatment and in Combinations 2016-08-02 |
Play |
| 4 | Keynote 55 Pembrolizumab for Heavily Pre-Treated Patients 2016-07-31 |
Play |
| 5 | Using Biomarkers in Immunotherapy 2016-07-28 |
Play |
| 6 | Common Side Effects of PD-1 Inhibitors 2016-07-20 |
Play |
| 7 | Data from Keynote 12 Nivolumab and Pembrolizumab 2016-07-19 |
Play |
| 8 | How Promising Are The Results From Checkmate 141? 2016-07-19 |
Play |
| 9 | The Immune System and PD-1 Inhibitors 2016-07-15 |
Play |
| 10 | Late Stage Oropharynx Cancer, Chemotherapy - Options and Practice (video) 2014-04-16 |
Play |
GRACEcast Head and Neck Cancer Video NEW
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
